naltrexone has been researched along with Diabetes Mellitus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| McLaughlin, PJ; Purushothaman, I; Sassani, JW; Zagon, IS; Zhou, S | 1 |
| McLaughlin, PJ; Purushothaman, I; Sassani, JW; Zagon, IS | 1 |
| Gwinn, KM; Hurren, KM; Makowski, CT | 1 |
| Agadjanov, MI; Agadjanova, EM; Batikyan, TB; Tadevosyan, YV; Vartanian, GS | 1 |
2 review(s) available for naltrexone and Diabetes Mellitus
| Article | Year |
|---|---|
Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.
Topics: Animals; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Dry Eye Syndromes; Enkephalins; Humans; Insulin; Naltrexone; Narcotic Antagonists; Receptors, Opioid | 2021 |
Naltrexone/bupropion: an investigational combination for weight loss and maintenance.
Topics: Anti-Obesity Agents; Bupropion; Diabetes Mellitus; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Naltrexone; Obesity; Quality of Life; Waist Circumference; Weight Loss | 2011 |
2 other study(ies) available for naltrexone and Diabetes Mellitus
| Article | Year |
|---|---|
Sex differences in the magnitude of diabetic ocular surface complications: Role of serum OGF.
Topics: Animals; Diabetes Mellitus; Eye; Female; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2021 |
Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus.
Topics: Benzylidene Compounds; Diabetes Mellitus; Diglycerides; Humans; In Vitro Techniques; Lymphocytes; Naltrexone; Oligopeptides; Phosphatidylinositols; Receptors, Opioid, delta; Signal Transduction | 2004 |